CAJ | 학술논문

目的探讨右旋美托咪啶(Dexmedetomidine,Dex)对男性病人麻醉前导尿的影响.方法择期手术男性病人60例(ASA Ⅰ~Ⅱ级),采用随机数字表随机分成Dex组和对照组：Dex组静脉泵注Dex负荷剂量1μg/kg(20 min泵完)；对照组入室后以同样方式泵注等量生理盐水,泵药完成后2 min导尿.记录病人在导尿时、导尿后5 min及导尿后10 min对导尿引起的疼痛不适的视觉模拟评分(VAS评分)；并比较首次导尿成功率.结果两组患者术前一般情况无显著差异.Dex组在导尿时、导尿后5 min、导尿后10 min的VAS评分明显低于对照组(P<0.05).Dex组和对照组的首次导尿成功率分别为96.7%和76.7%(P<0.05).结论右旋美托咪啶可以减轻男性病人导尿时和导尿后的疼痛不适感,并增加麻醉前导尿的首次成功率.
목적탐토우선미탁미정(Dexmedetomidine,Dex)대남성병인마취전도뇨적영향.방법택기수술남성병인60례(ASA Ⅰ~Ⅱ급),채용수궤수자표수궤분성Dex조화대조조：Dex조정맥빙주Dex부하제량1μg/kg(20 min빙완)；대조조입실후이동양방식빙주등량생리염수,빙약완성후2 min도뇨.기록병인재도뇨시、도뇨후5 min급도뇨후10 min대도뇨인기적동통불괄적시각모의평분(VAS평분)；병비교수차도뇨성공솔.결과량조환자술전일반정황무현저차이.Dex조재도뇨시、도뇨후5 min、도뇨후10 min적VAS평분명현저우대조조(P<0.05).Dex조화대조조적수차도뇨성공솔분별위96.7%화76.7%(P<0.05).결론우선미탁미정가이감경남성병인도뇨시화도뇨후적동통불괄감,병증가마취전도뇨적수차성공솔.
Objective To study the effect of dexmedetomidine(Dex) on urethral catheterization for male patients before anesthesia. Methods 60 male patients were randomized divided into dexmedetomidine group and control group. Dexmedetomidine was administered at a infusion dose of 1μg/kg in 20 minutes in Dex group, the same volume of physiological saline as placebo was administered in control group. Urinary catheter was inserted at 2 minutes after medication. Visual analogue scale(VAS) was recorded at 0,5 and 10 minutes after urethral catheterization had been done. The first-time achievment ratio of urethral catheterization between the two groups was compared.Results Before medication, the general conditions have no difference in the two groups. The VAS in the Dex group was lower than that in the control group at every time point(P<0.05).The first-time achievment ratio of urethral catheterization was 96.7% in the Dex group, which has significant difference compared with that in the control group (76.7%)(P<0.05). Conclusions Dexmedetomidine can reduce the pain and discomfort produced by urethral catheterization for male patients , and increase the achievment ratio of urethral catheterization before anesthesia.